Member Info for draft

Are this lot not putting their lung drug forward for covid trials???

Don't forget kirkstall just viewed everyone's tests at the animal free event. Live selection panel

I can't sleep. y r u awake

This drug met all its endpoints. ??

Shareholders as at over at deepmatter. Bet DMTR involved with this trial.

AstraZeneca will take this over I reckon. If they don't someone else will. Simple.

Already know about the US interest?

Know there is US interest here? Its in the press.

If you look on companies house, you will see MAC have picked up 84,000 shares in coldpress foods. That wasnt on the previous shares return for Coldpress juices. So macs got equity in the juice and island. Mac take fees and equity in their deal work. Now I suspect MAC will be very busy raising finance for hotels this month to get through covid.

The University of Glasgow has been awarded more than £1 million by the Scottish Government to undertake rapid Covid-19 research.

The funding will allow the university to start work on nine crucial coronavirus projects which will contribute to global efforts to combat the virus and its wider effects.

Research will be undertaken in key areas including treatments for the virus, underlying health conditions, secondary infections and the long terms effects of social distancing on the population.

Last month

https://www.sundaypost.com/fp/university-of-glasgow/

https://www.thegrocer.co.uk/plastic/could-coronavirus-be-the-last-straw-for-recycled-plastic/604535.article

is that a 22grand buy?

I reckon rns Monday, follow the money - look at those big buys at the end

this AI will transform big pharma development lead times, be interesting to see how much AZN have been paying and theyve probably enhanced their payments to DMTR cuz of the covid needs for a faster better drug

essentially we know DMTR Cronin already knocked out the 6 drugs via AI, now all he needs to do his mish mash them to come up with a brand new molecule taking the best parts from all 6

A European supercomputer is trawling through 10,000 drug molecules to find potential coronavirus treatments
??https://t.co/Afty5cjHL3 https://t.co/rgWGw0Qmlh

‘Our heart, lungs and digestive system all make noises and they can tell us a lot’: How artificial intelligence may help us detect coronavirus in the future
??https://t.co/OsN9fZm5bO https://t.co/fFk75A0Oy8

move up Monday

must be a placing overhang to clear

An exciting opportunity has arisen within the Beatson Drug Discovery Unit to join a three year collaboration project with Novartis to develop RAS inhibitor compounds for the treatment of KRAS driven cancers for which there is a substantial unmet clinical need. Computational Chemist
Starting salary £30,000 - £41,000 (Depending on experience)
3 year contract
Apply Here
The Drug Discovery Unit at the Beatson Institute in Glasgow, is one of four Cancer Research UK funded Drug Discovery Units across the UK. The aim of these units is to work closely with local cancer experts to maximise the opportunity to develop new and innovative therapies that strike at the core of cancer pathology. Using state of the art screening, advanced structural biology, industry standard computational and medicinal chemistry and complex biological modelling...Experience of working within a drug discovery environment would be an advantage
Strong oral and written communication skills required
Communicate and collaborate effectively with medicinal chemists, structural biologists and other members of cross-functional project teams
Knowledge of one programming or scripting language (such as Python, Java, C++ and R)
Good knowledge of UNIX/Linux
Ability to work independently and collaboratively in a multidisciplinary, team-oriented environment
Maintain and develop working knowledge of state-of-the-art computational chemistry methods and their application to drug design